Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations

Arti Hurria, William Dale, Margaret Mooney, Julia H. Rowland, Karla V. Ballman, Harvey J. Cohen, Hyman B. Muss, Richard L. Schilsky, Betty Ferrell, Martine Extermann, Kenneth E. Schmader, Supriya G. Mohile

Research output: Contribution to journalReview article

Abstract

A majority of cancer diagnoses and deaths occur in patients age ≥ 65 years. With the aging of the US population, the number of older adults with cancer will grow. Although the coming wave of older patients with cancer was anticipated in the early 1980s, when the need for more research on the cancer-aging interface was recognized, many knowledge gaps remain when it comes to treating older and/or frailer patients with cancer. Relatively little is known about the best way to balance the risks and benefits of existing cancer therapies in older patients; however, these patients continue to be underrepresented in clinical trials. Furthermore, the available clinical trials often do not include end points pertinent to the older adult population, such as preservation of function, cognition, and independence. As part of its ongoing effort to advance research in the field of geriatric oncology, the Cancer and Aging Research Group held a conference in November 2012 in collaboration with the National Cancer Institute, the National Institute on Aging, and the Alliance for Clinical Trials in Oncology. The goal was to develop recommendations and establish research guidelines for the design and implementation of therapeutic clinical trials for older and/or frail adults. The conference sought to identify knowledge gaps in cancer clinical trials for older adults and propose clinical trial designs to fill these gaps. The ultimate goal of this conference series is to develop research that will lead to evidence-based care for older and/or frail adults with cancer.

Original languageEnglish (US)
Pages (from-to)2587-2594
Number of pages8
JournalJournal of Clinical Oncology
Volume32
Issue number24
DOIs
StatePublished - Aug 20 2014
Externally publishedYes

Fingerprint

Frail Elderly
Clinical Trials
Neoplasms
Therapeutics
Research
National Institute on Aging (U.S.)
National Cancer Institute (U.S.)
Geriatrics
Cognition
Population
Research Design
Guidelines

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hurria, A., Dale, W., Mooney, M., Rowland, J. H., Ballman, K. V., Cohen, H. J., ... Mohile, S. G. (2014). Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. Journal of Clinical Oncology, 32(24), 2587-2594. https://doi.org/10.1200/JCO.2013.55.0418

Designing therapeutic clinical trials for older and frail adults with cancer : U13 conference recommendations. / Hurria, Arti; Dale, William; Mooney, Margaret; Rowland, Julia H.; Ballman, Karla V.; Cohen, Harvey J.; Muss, Hyman B.; Schilsky, Richard L.; Ferrell, Betty; Extermann, Martine; Schmader, Kenneth E.; Mohile, Supriya G.

In: Journal of Clinical Oncology, Vol. 32, No. 24, 20.08.2014, p. 2587-2594.

Research output: Contribution to journalReview article

Hurria, A, Dale, W, Mooney, M, Rowland, JH, Ballman, KV, Cohen, HJ, Muss, HB, Schilsky, RL, Ferrell, B, Extermann, M, Schmader, KE & Mohile, SG 2014, 'Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations', Journal of Clinical Oncology, vol. 32, no. 24, pp. 2587-2594. https://doi.org/10.1200/JCO.2013.55.0418
Hurria, Arti ; Dale, William ; Mooney, Margaret ; Rowland, Julia H. ; Ballman, Karla V. ; Cohen, Harvey J. ; Muss, Hyman B. ; Schilsky, Richard L. ; Ferrell, Betty ; Extermann, Martine ; Schmader, Kenneth E. ; Mohile, Supriya G. / Designing therapeutic clinical trials for older and frail adults with cancer : U13 conference recommendations. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 24. pp. 2587-2594.
@article{cab5f2c4260b417d873e3b8d429c918e,
title = "Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations",
abstract = "A majority of cancer diagnoses and deaths occur in patients age ≥ 65 years. With the aging of the US population, the number of older adults with cancer will grow. Although the coming wave of older patients with cancer was anticipated in the early 1980s, when the need for more research on the cancer-aging interface was recognized, many knowledge gaps remain when it comes to treating older and/or frailer patients with cancer. Relatively little is known about the best way to balance the risks and benefits of existing cancer therapies in older patients; however, these patients continue to be underrepresented in clinical trials. Furthermore, the available clinical trials often do not include end points pertinent to the older adult population, such as preservation of function, cognition, and independence. As part of its ongoing effort to advance research in the field of geriatric oncology, the Cancer and Aging Research Group held a conference in November 2012 in collaboration with the National Cancer Institute, the National Institute on Aging, and the Alliance for Clinical Trials in Oncology. The goal was to develop recommendations and establish research guidelines for the design and implementation of therapeutic clinical trials for older and/or frail adults. The conference sought to identify knowledge gaps in cancer clinical trials for older adults and propose clinical trial designs to fill these gaps. The ultimate goal of this conference series is to develop research that will lead to evidence-based care for older and/or frail adults with cancer.",
author = "Arti Hurria and William Dale and Margaret Mooney and Rowland, {Julia H.} and Ballman, {Karla V.} and Cohen, {Harvey J.} and Muss, {Hyman B.} and Schilsky, {Richard L.} and Betty Ferrell and Martine Extermann and Schmader, {Kenneth E.} and Mohile, {Supriya G.}",
year = "2014",
month = "8",
day = "20",
doi = "10.1200/JCO.2013.55.0418",
language = "English (US)",
volume = "32",
pages = "2587--2594",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "24",

}

TY - JOUR

T1 - Designing therapeutic clinical trials for older and frail adults with cancer

T2 - U13 conference recommendations

AU - Hurria, Arti

AU - Dale, William

AU - Mooney, Margaret

AU - Rowland, Julia H.

AU - Ballman, Karla V.

AU - Cohen, Harvey J.

AU - Muss, Hyman B.

AU - Schilsky, Richard L.

AU - Ferrell, Betty

AU - Extermann, Martine

AU - Schmader, Kenneth E.

AU - Mohile, Supriya G.

PY - 2014/8/20

Y1 - 2014/8/20

N2 - A majority of cancer diagnoses and deaths occur in patients age ≥ 65 years. With the aging of the US population, the number of older adults with cancer will grow. Although the coming wave of older patients with cancer was anticipated in the early 1980s, when the need for more research on the cancer-aging interface was recognized, many knowledge gaps remain when it comes to treating older and/or frailer patients with cancer. Relatively little is known about the best way to balance the risks and benefits of existing cancer therapies in older patients; however, these patients continue to be underrepresented in clinical trials. Furthermore, the available clinical trials often do not include end points pertinent to the older adult population, such as preservation of function, cognition, and independence. As part of its ongoing effort to advance research in the field of geriatric oncology, the Cancer and Aging Research Group held a conference in November 2012 in collaboration with the National Cancer Institute, the National Institute on Aging, and the Alliance for Clinical Trials in Oncology. The goal was to develop recommendations and establish research guidelines for the design and implementation of therapeutic clinical trials for older and/or frail adults. The conference sought to identify knowledge gaps in cancer clinical trials for older adults and propose clinical trial designs to fill these gaps. The ultimate goal of this conference series is to develop research that will lead to evidence-based care for older and/or frail adults with cancer.

AB - A majority of cancer diagnoses and deaths occur in patients age ≥ 65 years. With the aging of the US population, the number of older adults with cancer will grow. Although the coming wave of older patients with cancer was anticipated in the early 1980s, when the need for more research on the cancer-aging interface was recognized, many knowledge gaps remain when it comes to treating older and/or frailer patients with cancer. Relatively little is known about the best way to balance the risks and benefits of existing cancer therapies in older patients; however, these patients continue to be underrepresented in clinical trials. Furthermore, the available clinical trials often do not include end points pertinent to the older adult population, such as preservation of function, cognition, and independence. As part of its ongoing effort to advance research in the field of geriatric oncology, the Cancer and Aging Research Group held a conference in November 2012 in collaboration with the National Cancer Institute, the National Institute on Aging, and the Alliance for Clinical Trials in Oncology. The goal was to develop recommendations and establish research guidelines for the design and implementation of therapeutic clinical trials for older and/or frail adults. The conference sought to identify knowledge gaps in cancer clinical trials for older adults and propose clinical trial designs to fill these gaps. The ultimate goal of this conference series is to develop research that will lead to evidence-based care for older and/or frail adults with cancer.

UR - http://www.scopus.com/inward/record.url?scp=84906241905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906241905&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.55.0418

DO - 10.1200/JCO.2013.55.0418

M3 - Review article

C2 - 25071116

AN - SCOPUS:84906241905

VL - 32

SP - 2587

EP - 2594

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 24

ER -